In an interview on CNBC’s Mad Money, Leon Topalian said Nucor (NUE) is on a $16B investment campaign. “We’re thinking about our long term growth position,” he noted. “We’re hitting on a lot of cylinders right now.” The company is running at an 85% utilization rate “with plenty to go.” He expects Nucor to be EBITDA positive in Q1. Pricing and backlogs are up in every category, he added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NUE:
- Nucor price target raised to $165 from $152 at Morgan Stanley
- Nucor’s Strategic Advantage: Buy Rating Amid Tariff Protections and Revised Earnings Outlook
- Nucor’s Strong Q3 Performance and Strategic Initiatives Justify Buy Rating with $165 Price Target
- Nucor Reports Q3 2025 Earnings Increase
- Nucor reports Q3 adjusted EPS $2.63, consensus $2.16